Capricor Therapeutics Reports Second Quarter 2016 Financial Results and Provides Clinical Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. ACN
3. NVDA
4. APGE
5. USO
6. GOOGL
7. MU
8. HOOD
9. DFTX
10. RGNX

Go back to Capricor Therapeutics Reports Second Quarter 2016 Financial Results and Provides Clinical Update

Capricor Therapeutics (CAPR) Misses Q2 EPS by 2c

August 15, 2016 4:45 PM EDT

Capricor Therapeutics (NASDAQ: CAPR) reported Q2 EPS of ($0.26), $0.02 worse than the analyst estimate of ($0.24).

For earnings history and earnings-related data on Capricor Therapeutics (CAPR) click here.

... More